The ROE as of December 2024 (TTM) for Tenax Therapeutics, Inc. (TENX) is -22.00%

According to Tenax Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -22.00%. This represents a change of 64.06% compared to the average of -13.41% of the last 4 quarters.

Tenax Therapeutics, Inc. (TENX) Historical ROE (quarterly & annually)

How has TENX ROE performed in the past?

The mean historical ROE of Tenax Therapeutics, Inc. over the last ten years is -250.19%. The current -22.00% ROE has changed -91.21% with respect to the historical average. Over the past ten years (40 quarters), TENX's ROE was at its highest in in the March 2024 quarter at 30.56%. The ROE was at its lowest in in the March 2021 quarter at -767.14%.

Tenax Therapeutics, Inc. (TENX) ROE by Quarter and Year

Discovering the peaks and valleys of Tenax Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tenax Therapeutics, Inc. (TENX) Average ROE

How has TENX ROE performed in the past?

The current ROE of Tenax Therapeutics, Inc. (TENX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tenax Therapeutics, Inc. (TENX) ROE vs. Peers

How is TENX’s ROE compared to its peers?

Tenax Therapeutics, Inc.’s ROE is greater than Allarity Therapeutics, Inc. (-328.22%), greater than NeuroBo Pharmaceuticals, Inc. (-189.12%), greater than Hillstream BioPharma, Inc. (-172.28%), greater than Virax Biolabs Group Limited (-115.10%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than PaxMedica, Inc. Common Stock (-3167.06%), greater than Revelation Biosciences, Inc. (-311.33%), greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), less than Altamira Therapeutics Ltd. (783.37%), greater than Windtree Therapeutics, Inc. (-115.33%), greater than Dermata Therapeutics, Inc. (-247.40%), greater than Ensysce Biosciences, Inc. (-268.39%), less than Panbela Therapeutics, Inc. (304.71%), less than Baudax Bio, Inc. (0%), greater than Aditxt, Inc. (-431.38%), greater than Unicycive Therapeutics, Inc. (-374.14%),

Build a custom stock screener for Tenax Therapeutics, Inc. (TENX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tenax Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tenax Therapeutics, Inc. (TENX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tenax Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.